Latest filings (excl ownership)
DEF 14A
Definitive proxy
9 Apr 24
8-K
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
5 Apr 24
PRE 14A
Preliminary proxy
25 Mar 24
8-K
Other Events
7 Mar 24
8-K
Other Events
23 Feb 24
8-K
Entry into a Material Definitive Agreement
26 Jan 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
8-K
Termination of a Material Definitive Agreement
28 Dec 23
424B3
Prospectus supplement
28 Dec 23
8-K
Termination of a Material Definitive Agreement
22 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Nov 23
8-K
Other Events
20 Oct 23
8-K
Entry into a Material Definitive Agreement
18 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
29 Sep 23
DEFA14A
Additional proxy soliciting materials
18 Sep 23
8-K
Amendments to Articles of Incorporation or Bylaws
18 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
11 Aug 23
DEFA14A
Additional proxy soliciting materials
11 Aug 23
DEF 14A
Definitive proxy
11 Aug 23
EFFECT
Notice of effectiveness
11 Aug 23
424B3
Prospectus supplement
10 Aug 23
CORRESP
Correspondence with SEC
7 Aug 23
8-K
NeuBase Therapeutics to Explore Strategic Alternatives
3 Aug 23
UPLOAD
Letter from SEC
3 Aug 23
PRE 14A
Preliminary proxy
1 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
S-1
IPO registration
28 Jul 23
D
Exempt offering of security
7 Jul 23
8-K
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
30 Jun 23
424B5
Prospectus supplement for primary offering
30 Jun 23
424B3
Prospectus supplement
30 Jun 23
8-K
NeuBase Announces 1-for-20 Reverse Stock Split
14 Jun 23
10-QT
Quarterly report for transitional period
5 Jun 23
8-K
Regulation FD Disclosure
22 May 23
8-K
Departure of Directors or Certain Officers
18 May 23
8-K
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
11 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
24 Apr 23
Latest ownership filings
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 24
5
Aleta Shiff
20 Sep 23
SC 13D/A
Symetryx Corp
20 Sep 23
4
Change in insider ownership
18 Sep 23
SC 13D/A
Symetryx Corp
14 Sep 23
3/A
Aleta Shiff
12 Sep 23
4
Change in insider ownership
11 Sep 23
4
Change in insider ownership
7 Sep 23
3
Initial statement of insider ownership
1 Sep 23
SC 13D
Symetryx Corp
31 Aug 23
4
Dietrich A Stephan
4 Aug 23
4
Todd P. Branning
17 Mar 23
4
Dietrich A Stephan
17 Mar 23
4
Dietrich A Stephan
15 Feb 23
SC 13G/A
Kershner Trading Americas,LLC
27 Jan 23
4
Todd P. Branning
4 Nov 22
4
Dietrich A Stephan
30 Sep 22
4
ERIC I RICHMAN
12 Sep 22
4
FRANKLYN G PRENDERGAST
12 Sep 22
4
Gerald J McDougall
12 Sep 22
4
DOV A MD GOLDSTEIN
12 Sep 22
4
Eric J Ende
12 Sep 22
4
William Roland Mann
1 Apr 22
4
Todd P. Branning
21 Mar 22
4
Todd P. Branning
18 Mar 22
4
ERIC I RICHMAN
7 Mar 22
SC 13G/A
GREENLIGHT CAPITAL INC
14 Feb 22
4
William Roland Mann
25 Jan 22
4
Sandra Rojas-Caro
25 Jan 22
4
Dietrich A Stephan
25 Jan 22
4
Todd P. Branning
10 Jan 22
3
Todd P. Branning
10 Jan 22
4
Dietrich A Stephan
5 Jan 22
4
Eric J Ende
5 Jan 22
3
Eric J Ende
5 Jan 22
4
William Roland Mann
24 Sep 21
4
Gerald J McDougall
17 Sep 21
4
DOV A MD GOLDSTEIN
17 Sep 21
4
FRANKLYN G PRENDERGAST
17 Sep 21
4
ERIC I RICHMAN
17 Sep 21